Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orlistat plus insulin in overweight or obese adults with type 2 diabetes mellitus
ChiCTR2000037825Phase 4Recruiting
- Sponsor
- Shantou Longhu People's Hospital
- Start
- Aug 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of orlistat and human insulin in type 2 diabetes mellitus (T2DM), obesity and Overweight (2 arms), sponsored by Shantou Longhu People's Hospital. Primary endpoints: Weight, Blood glucose control and 3 more. Started Aug 2020; status: recruiting.
02
Drugs
orlistathuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)obesityOverweight
Beyond the preview
Go deeper on ChiCTR2000037825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037825.